unodelacosa
Bluelighter
They are similar, and if you have the hydrochloride salt, they are about the same in dose with 6-APB maybe slightly more potent. But if you have the succinate salt, do note that it's ~36% less potent by weight compared to the HCl. Both drugs are mildly psychedelic but large doses of MDA get pretty trippy whereas 6-APB has more of a stimulant factor to it. MDA can get derpy and I pass out at the end of the roll, but 6-APB has more of an amphetamine-like kick to it. Also, the recovery from MDA afterward is harsher than 6-APB which I didn't feel was much challenge at all.Could somebody who had both MDA and 6-APB compare their effects?
I've never been totally sold on any of the benzofuran ring-class ecstasy substitutes like it, including 5-APB, its n-methyl derivative, 5-MAPB, and 6-MAPB which switches the location of the solo oxygen atom in the furan ring to the opposite side of the ring. I've tried the "Borax combo" that's supposed to mimic MDMA, but it comes up short in my opinion. Nothing does what MDMA does in terms of sheer empathy and living in the present moment whilst being bathed in a wonderful anxiolysis, first and foremost, with MDA as a close runner-up (though distinct ☞ more psychedelia, less empathy). Yes, MDMA and MDA are neurotoxic, but then so is drinking ethyl alcohol. Brain cells die every single time one drinks booze, and it's a class 1 carcinogen to boot.
Benzofury drugs are probably cardiotoxic as they cause a good bit of tachycardia and show preference for the 5-HT2B serotonin receptor subtype. If you use them, avoid large doses and use very sparingly. Most people will consider 6-APB either "mellow" and "weak" with small to medium doses, or with larger doses, "speedy" and/or "gritty".
Dr. David Nichols and his group at Purdue studied 6-APB to determine if it could be a good, less-neurotoxic stand-in for MDMA that still affords a clinical utility for therapy. The trouble is, like I was saying it shows some 100 fold increase in affinity for the 5-HT2B receptor which regulates heart function while its norepinephrine/adrenergic activity leads to tachycardia. As such, just to reiterate the point: 6-APB is likely cardiotoxic, especially w/chronic use. But again, to be fair, cocaine is cardiotoxic, too, so occasional use of 6-APB probably won't dole out significant enough cardiotoxicity to worry about, in my estimate anyway, but I'm no cardiac specialist, and more research on this topic needs to be done to come to better conclusions regarding the extent of cardiotoxicity…
Despite all of this, demand for benzofury drugs has risen and accordingly so has the price most vendors I've seen are charging for them. We're not supposed to discuss exact drug prices per the forum rules, so I won't get into the details here beyond saying that the value proposition doesn't warrant the price, especially when one considers how the market value for the original compounds these would replace has dropped, likely thanks to an increase in global supply. Whenever this happens, the less scrupulous types start seeing dollar signs (or Euro marks, whatever, you get the gist), and it's important to test your drugs and consider doing "allergy test" amounts at first.
From Psychonautwiki:
6-APB is a serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) with Ki values of 117, 150, and 2698 nM for the norepinephrine transporter (NET), dopamine transporter (DAT), and serotonin transporter (SERT), respectively.[4] 6-APB also possesses additional activity as a releasing agent of these monoamine neurotransmitters.[5]
6-APB is a potent full agonist of the serotonin 5-HT2B receptor (Ki = 3.7 nM)[4], with higher affinity for this target than any other site.[6] Moreover, unlike MDMA, 6-APB shows 100-fold selectivity for the 5-HT2B receptor over the 5-HT2A and 5-HT2C receptors.[6][7]
Aside from the 5-HT2B receptor, 6-APB has also been found to bind with high affinity to the α2C-adrenergic receptor subtype (Ki = 45 nM), although the clinical significance of this action is unknown.[4]
The potent agonism of the 5-HT2B receptor makes it likely that 6-APB would be cardiotoxic with chronic or long-term use, as seen with other 5-HT2B receptor agonists such as the withdrawn serotonergic anorectic fenfluramine
Last edited: